Jaguar Health — Valuation, Funding & Investors

Recent changes

Jul 15, 2026Jul 15, 2026Jaguar Health, Vogenx Join a Growing Biotech S-1 Queue Pulse story
Jun 9, 2026Jun 9, 2026Raised $2M SEC EDGAR Form D

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Jun 9, 2026	funding round	$2M	—		SEC EDGAR Form D

Latest Pulse

Jul 15, 2026Jaguar Health, Vogenx Join a Growing Biotech S-1 QueueJaguar Health and Vogenx both filed S-1 paperwork with the SEC, adding to a biotech IPO queue that's grown steadily through 2026 as public-market appetite for clinical-stage listings recovers.→

Coverage Timeline

newest first

Jul 15, 2026IPOJaguar Health, Vogenx Join a Growing Biotech S-1 Queue→

All Coverage

IPO· Jul 15, 2026

Jaguar Health, Vogenx Join a Growing Biotech S-1 Queue

IPO

Jaguar Health, Vogenx Join a Growing Biotech S-1 Queue

Jaguar Health and Vogenx both filed S-1 paperwork with the SEC, adding to a biotech IPO queue that's grown steadily through 2026 as public-market appetite for clinical-stage listings recovers.

Jul 15, 2026

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics

Sources & methodologyshow

Where these figures come from

SEC EDGAR Form Dprimary source1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction